Related Experiment Video
Updated: Aug 8, 2026

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs)
Published on: March 2, 2018
Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma
Jan J Molenaar1, Peter van Sluis, Kathy Boon
1Department of Human Genetics, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Abstract:
Cyclin D1 regulates G1 cell cycle progression by controlling the phosphorylation of the retinoblastoma protein. This pathway is frequently deregulated in many malignancies. In neuroblastoma, however, no consistent G1 cell cycle checkpoint aberrations have been found. We examined the possible deregulation of cyclin D1 (CCND1) in this tumor. mRNA expression profiles of neuroblastoma generated by SAGE (Serial Analysis of Gene Expression) revealed a high expression of CCND1 in a subset of neuroblastoma cell lines and tumors. The CCND1 expression level can be 0.3% of the total cellular mRNA. Northern blot analysis of CCND1 expression showed a relative overexpression in 16 of 23 neuroblastoma cell lines and 10 of 15 tumor samples. In the majority of cases, the high CCND1 mRNA levels also led to high CCND1 protein levels. In the search for mechanisms causing this relative overexpression, we screened for amplifications and rearrangements of CCND1. Five amplifications were found in 202 neuroblastoma tumors and cell lines. Analysis of the 3'-UTR of CCND1 showed a rearrangement in 1 of 96 tumors. These clonal aberrations of CCND1 together with the high expression suggest a role for deregulated CCND1 activity in neuroblastoma tumorigenesis.
Insights
Cyclin D1 (CCND1) is overexpressed in some neuroblastomas, suggesting its deregulation contributes to tumor development. Researchers found high CCND1 mRNA and protein levels, with some tumors showing CCND1 gene amplification or rearrangement.
Area of Science:
- Oncology
- Molecular Biology
- Cell Cycle Regulation
Background:
- Cyclin D1 (CCND1) controls cell cycle progression and is often deregulated in cancers.
- Neuroblastoma typically lacks consistent G1 cell cycle checkpoint aberrations.
Purpose of the Study:
- To investigate the potential deregulation of cyclin D1 (CCND1) in neuroblastoma.
- To determine if CCND1 overexpression or genetic alterations play a role in neuroblastoma tumorigenesis.
Main Methods:
- Serial Analysis of Gene Expression (SAGE) for mRNA profiling.
- Northern blot analysis for CCND1 expression.
- Screening for CCND1 gene amplifications and rearrangements.
Main Results:
- High CCND1 mRNA expression was observed in a subset of neuroblastoma cell lines and tumors (up to 0.3% of total mRNA).
- Relative CCND1 overexpression was confirmed in 16/23 cell lines and 10/15 tumors, correlating with elevated protein levels.
- CCND1 gene amplifications were found in 5/202 samples, and a rearrangement in 1/96 tumors.
Conclusions:
- Relative overexpression of CCND1 occurs in neuroblastoma.
- Clonal aberrations of CCND1, alongside high expression, suggest its deregulated activity contributes to neuroblastoma development.
Related Concept Videos
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

